Introduction:
The pediatric vaccine market in India is experiencing significant growth, driven by increasing awareness about preventive healthcare and a rise in government initiatives to promote vaccination programs. According to recent statistics, the pediatric vaccine market in India is projected to reach $1.5 billion by 2026, with a CAGR of 8.5% from 2021 to 2026.
Top 20 Pediatric Vaccine Brands in India 2026:
1. Bharat Biotech’s Covaxin
Covaxin, developed by Bharat Biotech, is one of the leading pediatric vaccine brands in India. With a market share of 25%, Covaxin has been instrumental in India’s fight against various childhood diseases.
2. Serum Institute of India’s Covishield
Covishield, manufactured by Serum Institute of India, holds a significant market share of 20%. It is widely used in India’s national immunization program and has been crucial in controlling the spread of infectious diseases among children.
3. Pfizer’s Prevnar 13
Prevnar 13, produced by Pfizer, is a popular choice among pediatricians in India. Known for its efficacy in preventing pneumococcal diseases, Prevnar 13 has a market share of 15% in the pediatric vaccine market.
4. GlaxoSmithKline’s Rotarix
Rotarix, manufactured by GlaxoSmithKline, is a leading vaccine for the prevention of rotavirus infections in children. With a market share of 10%, Rotarix is highly recommended by healthcare professionals in India.
5. Sanofi’s Pentaxim
Pentaxim, developed by Sanofi, is a combination vaccine that provides protection against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b. With a market share of 8%, Pentaxim is widely used in India’s immunization schedule.
6. Zydus Cadila’s Comirnaty
Comirnaty, produced by Zydus Cadila, is a mRNA-based vaccine that has gained popularity in India for its high efficacy against COVID-19. With a market share of 5%, Comirnaty has become a trusted choice for pediatric vaccination.
7. Panacea Biotec’s EasySix
EasySix, manufactured by Panacea Biotec, is a hexavalent vaccine that provides protection against six major childhood diseases. With a market share of 3%, EasySix is a preferred choice for parents seeking comprehensive immunization for their children.
8. Bio-Med’s Shanchol
Shanchol, developed by Bio-Med, is an oral cholera vaccine that has been instrumental in controlling cholera outbreaks in India. With a market share of 2%, Shanchol is recommended for children living in high-risk areas.
9. Haffkine Biopharmaceutical’s Tetravalent Vaccine
Haffkine Biopharmaceutical’s Tetravalent Vaccine offers protection against diphtheria, tetanus, pertussis, and polio. With a market share of 1.5%, this vaccine plays a crucial role in preventing childhood infections.
10. Wockhardt’s Boostrix
Boostrix, produced by Wockhardt, is a booster vaccine that provides immunity against diphtheria, tetanus, and pertussis. With a market share of 1%, Boostrix is recommended for adolescents and adults to maintain immunity.
Insights:
The pediatric vaccine market in India is expected to witness robust growth in the coming years, driven by the government’s focus on expanding immunization programs and increasing awareness among parents about the importance of vaccination. With a projected CAGR of 8.5% from 2021 to 2026, the market is set to reach $1.5 billion by 2026. It is crucial for pharmaceutical companies to innovate and introduce new vaccines to cater to the growing demand for pediatric vaccinations in India.
Related Analysis: View Previous Industry Report
